China Oncology ›› 2013, Vol. 23 ›› Issue (7): 547-550.doi: 10.3969/j.issn.1007-3969.2013.07.012

Previous Articles     Next Articles

Advances in the study of deubiquitinating enzymes in cancer research

DAI Chen-xin, YUAN Jian, ZHENG Ya-xin   

  1. 1.Department of Liver Disease, East Hospital, Tongji University, Shanghai 200120, China;
    2.Research Center for Translational Medicine, East Hospital, Tongji University, Shanghai 200120, China
  • Online:2013-07-25 Published:2014-03-03
  • Contact: ZHENG Ya-xin E-mail: zheng021@yahoo.com

Abstract:

Deubiquitinating enzymes, reversing protein ubiquitination, most of the researches focused on the field of molecular biology. However, it have not yet attracted enough attention in translational medicine research. In fact, target proteins of deubiquitinating enzymes affect the tumor progression through various ways, for example, cell apoptosis and autophagy, the link between inflammation and cancer, tumor hypoxia, signal transduction, cell cycle regulation and DNA damage. This paper reviewed the research progress on the relations between deubiquitinating enzymes and the correlated factors of tumor.

Key words: Deubiquitination, Neoplasms, Apoptosis, Signal transduction, Cell cycle